Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
![HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/8602/1/fig-1-full.png "HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]")
HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]
Comprehensive assessment of HER2 alteration in a colorectal cancer coh | CMAR
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target | American Society of Clinical Oncology Educational Book
Tucatinib Approved for HER2-Positive Colorectal Cancer - NCI
HER2 Biomarker | Colorectal Cancer Alliance
Dual HER2 Blockade in Patients With HER2-Amplified Metastatic
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review - ScienceDirect
Anti-HER2 Agents Gain Ground in Colorectal Cancer
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study | Modern Pathology
Fulfilling the potential of HER2-targeting in colorectal cancer: update on detection and management - YouTube
HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function | Scientific Reports
Clinical significance of HER2 and EGFR expression in colorectal cancer patients with ovarian metastasis | BMC Clinical Pathology | Full Text
![PDF] Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/94e7ce3cbf29365fa3c4053b007a40513f46b3af/3-Figure1-1.png "PDF] Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status | Semantic Scholar")
PDF] Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status | Semantic Scholar
Dual HER2 Blockade in Patients With HER2-Amplified Metastatic
Life | Free Full-Text | HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes
HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression | PLOS ONE
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer - ScienceDirect
IJMS | Free Full-Text | Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer
Q&A column - CAP TODAY
Frontiers | Remarkable Response of EGFR- and HER2-Amplified Metastatic Colon Cancer to Pyrotinib After Failed Multiline Treatments: A Case Report and Literature Review
IJMS | Free Full-Text | Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer | BMC Cancer | Full Text
